TBX4-PRECIS TBX4 enhancer based precision gene targeting for lung health
- Coordinator
- Justus-Liebig-Universitaet Giessen, Germany
- Runs
- 1 August 2026 to 31 January 2028
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101334858
What the project is doing
In the project's own words, from its summary on CORDIS.
Chronic respiratory diseases (CRDs) represent a major global health burden, with limited therapeutic options available. Gene therapy offers significant potential; however, current approaches often lack organ specificity, resulting in off-target effects. TBX4-PRECIS is a novel lung-specific gene delivery platform based on a uniquely engineered genetic sequence that enables precise targeting of therapeutic genes to the lung.
Unlike conventional promoter-based systems, TBX4-PRECIS provides highly specific, carrier-agnostic expression of transgenes or antisense molecules in lung tissue, thereby improving targeting precision and minimizing off-target activity.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Justus-Liebig-Universitaet Giessen | Giessen | Germany | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI